Clinical pharmacology of corticosteroids
DM Williams - Respiratory care, 2018 - rc.rcjournal.com
Corticosteroids have numerous applications in treating inflammation and diseases of
immune function based on their significant anti-inflammatory and immunosuppressive …
immune function based on their significant anti-inflammatory and immunosuppressive …
Aerosol drug delivery: developments in device design and clinical use
MB Dolovich, R Dhand - The Lancet, 2011 - thelancet.com
Aerosolised drugs are prescribed for use in a range of inhaler devices and systems.
Delivering drugs by inhalation requires a formulation that can be successfully aerosolised …
Delivering drugs by inhalation requires a formulation that can be successfully aerosolised …
Asthma outcomes: biomarkers
BACKGROUND: Measurement of biomarkers has been incorporated within clinical research
studies of asthma to characterize the population and associate the disease with …
studies of asthma to characterize the population and associate the disease with …
Asthma outcomes: exacerbations
BACKGROUND: The goals of asthma treatment include preventing recurrent exacerbations.
Yet there is no consensus about the terminology for describing or defining “exacerbation” or …
Yet there is no consensus about the terminology for describing or defining “exacerbation” or …
Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications
NR Labiris, MB Dolovich - British journal of clinical …, 2003 - Wiley Online Library
Research in the area of pulmonary drug delivery has gathered momentum in the last several
years, with increased interest in using the lung as a means of delivering drugs systemically …
years, with increased interest in using the lung as a means of delivering drugs systemically …
Significant variability in response to inhaled corticosteroids for persistent asthma
SJ Szefler, RJ Martin, TS King, HA Boushey… - Journal of Allergy and …, 2002 - Elsevier
Background: A clinical model is needed to compare inhaled corticosteroids (ICSs) with
respect to efficacy. Objective: The purpose of this investigation was to compare the relative …
respect to efficacy. Objective: The purpose of this investigation was to compare the relative …
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma
SC Lazarus, VM Chinchilli, NJ Rollings… - American journal of …, 2007 - atsjournals.org
Rationale: One-quarter to one-third of individuals with asthma smoke, which may affect
response to therapy and contribute to poor asthma control. Objectives: To determine if the …
response to therapy and contribute to poor asthma control. Objectives: To determine if the …
Update on glucocorticoid action and resistance
Extensive development of inhaled and oral glucocorticoids has resulted in highly potent
molecules that have been optimized to target activity to the lung and minimize systemic …
molecules that have been optimized to target activity to the lung and minimize systemic …
[HTML][HTML] Systemic side effects of inhaled corticosteroids in patients with asthma
R Dahl - Respiratory medicine, 2006 - Elsevier
Asthma is a complex disease of the respiratory tract associated with chronic inflammation in
which an intricate network of cells and cellular factors plays a major role. Asthma is one of …
which an intricate network of cells and cellular factors plays a major role. Asthma is one of …
Asthma and obstructive sleep apnea overlap: what has the evidence taught us?
B Prasad, SM Nyenhuis, I Imayama… - American journal of …, 2020 - atsjournals.org
Obstructive sleep apnea (OSA) and asthma are highly prevalent chronic respiratory
disorders. Beyond their frequent coexistence arising from their high prevalence and shared …
disorders. Beyond their frequent coexistence arising from their high prevalence and shared …